30/04/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

30/04/2024

Apr 30, 2024, 12:48 | Insight
CAGLA's Marc Matrana won the very prestigious Ochsner Academic award
Marc Matrana, System Director of Precision Medicine, shared a post by Cancer Advocacy Group of…
Apr 30, 2024, 12:41 | Blog
Julie Gralow: Honored to receive this award
Julie Gralow shared post by ASCO on X, adding: "Honored to receive this award, and a copy…
Apr 30, 2024, 12:41 | Insight
Nils Rudqvist: Full support for Sandra Demaria as she is running to become the next SITC vice president!
Nils Rudqvist, Director and Scientific Strategic Program Manager at Agenus, shared a post on LinkedIn:…
Apr 30, 2024, 12:27 | Blog
Kimryn Rathmell: NIH welcomed 'The Ladder' statue by Mary Ellen Scherl
Kimryn Rathmell, Director of National Cancer Institute, shared on X/Twitter: "On National DNA Day, NIH…
Apr 30, 2024, 12:22 | Insight
Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy
Harold Burstein, Breast Cancer Specialist and Professor at Dana Farber Cancer Institute, shared a post…
Apr 30, 2024, 12:12 | Insight
Roupen Odabashian: How cancer treatment decisions are made
Quoting Roupen Odabashian on LinkedIn: "This is another article on how cancer treatment decisions are…
Apr 30, 2024, 11:56 | Blog
Manmeet Ahluwalia: It is my privilege to be the keynote speaker at my Alma mater
Manmeet Ahluwalia, Chief Scientific Officer, Chief of Medical Oncology, and Deputy Director of Miami Cancer…
Apr 30, 2024, 11:41 | Blog
Sendurai Mani: My lab is seeking a postdoctoral candidate to join our team and to study pancreatic cancer
Sendurai Mani shared on LinkedIn: "My lab is seeking a postdoctoral candidate  to join our…
Apr 30, 2024, 11:32 | Opinion
Ishwaria Subbiah: Colleagues with a sense of humor are priceless!
Ishwaria Subbiah shared on LinkedIn: "Colleagues with a sense of humor are priceless! Oncology is…
Apr 30, 2024, 11:17 | Insight
New Paper Alert! Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer
Targeting NECTIN4. Predicting Response to Enfortumab Vedotin in Metastatic Urothelial Cancer Authors: Niklas Klümper, MD,…
All: 63 Posts: 31 - 40
Special Coverage